Results

Total Results: 345 records

Showing results for "obesity".

321. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - history, and hormonal factors (age at menarche and menopause)—are not easily modifiable. 4-12 Although obesity

322. Recommendation: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
     May 18, 2021 - syndrome or familial adenomatous polyposis), 8 men, 2 and persons with other risk factors (such as obesity

323. Q Nxyq7Cwpbuwvt27Sq42 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q__nXYQ7cWPBuwvt27sQ42
     July 01, 2013 - specific to GDM, and much of the risk for such outcomes is attributable to other factors, such as maternal obesity

324. High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/2023-annual-report-to-congress.pdf
     January 01, 2023 - He practices family medicine and leads the medical obesity treatment program.

325. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r3f2G_ReqS8tN48szHPCxt
     November 01, 2009 - 2002 or prescription of tamoxifen or other agents for primary disease prevention; increasing rates of obesity

326. PII: S0749-3797(01)00261-6 (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
     January 01, 2001 - gestational diabetes Screening for asymptomatic coronary artery disease Screening for dementia Screening for obesity

327. 14th Annual Report to Congress: High-Priority Evidence Gaps Across the Lifespan, in All Communities (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
     January 01, 2024 - He practices family medicine and leads the medical obesity treatment program.

328. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
     April 25, 2017 - Studies of current prenatal care populations, with a higher prevalence of obesity and other preeclampsia

329. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
     July 18, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Lipid Disorders in Children and Adolescents: Screening July 18, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They shoul…

330. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
     August 23, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication August 23, 2022 Recommendations made by the USPSTF are inde…

331. Evidence Summary: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary--html/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality

332. Nz Rqwxmmr8Vym-Yjuqru- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
     May 23, 2019 - compared with offering these programs more generally to persons with such risk factors for diabetes as obesity

333. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
     July 18, 2023 - Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Screening for Lipid Disorders in Children and Adolescents Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Janelle M. Guirguis-Blake…

334. Behavioral Counseling Interventions: An Evidence-based Approach | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-interventions-evidence-based-approach
     March 04, 2021 - Behavioral Counseling Interventions: An Evidence-based Approach Share to Facebook Share to X Share to WhatsApp Share to Email Print Table of Contents Preface Abstract Introduction Background Rationale for Behavioral Counseling Interventions i…

335. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
     February 03, 2003 - compared with offering these programs more generally to persons with such risk factors for diabetes as obesity

336. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
     April 15, 2013 - Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence

337. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence

338. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MWRHULpw6y_5Uk_KXTyvp8
     January 10, 2017 - folic acid daily for 3 months or less prior to conception; when adjusted for maternal age, education, obesity

339. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_nVeFxDCT9L-_cnDf_V3fK
     July 17, 2018 - Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality

340. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medica…